Product NDC: | 67457-238 |
Proprietary Name: | Fludarabine Phosphate |
Non Proprietary Name: | Fludarabine Phosphate |
Active Ingredient(s): | 25 mg/mL & nbsp; Fludarabine Phosphate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-238 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090724 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130130 |
Package NDC: | 67457-238-02 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-238-02) > 2 mL in 1 VIAL, GLASS |
NDC Code | 67457-238-02 |
Proprietary Name | Fludarabine Phosphate |
Package Description | 1 VIAL, GLASS in 1 CARTON (67457-238-02) > 2 mL in 1 VIAL, GLASS |
Product NDC | 67457-238 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludarabine Phosphate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130130 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | FLUDARABINE PHOSPHATE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |